Showing 1 to 2 of 2 results


France Expands Access to Anti-Obesity Drugs
The French government will allow general practitioners to prescribe Wegovy and Mounjaro to combat obesity, affecting nearly 50% of French adults; a plan launching in September will address this through education, healthcare, sports, and medication, aiming to curb cardiovascular deaths.
France Expands Access to Anti-Obesity Drugs
The French government will allow general practitioners to prescribe Wegovy and Mounjaro to combat obesity, affecting nearly 50% of French adults; a plan launching in September will address this through education, healthcare, sports, and medication, aiming to curb cardiovascular deaths.
Progress
40% Bias Score

Weekly Semaglutide Shows Promise in Reducing Alcohol Consumption
A JAMA Psychiatry study shows weekly semaglutide significantly reduced alcohol cravings and heavy drinking days in 48 adults with alcohol use disorder, with nearly 40% of the semaglutide group reporting no heavy drinking days in the final month versus 20% in the placebo group.

Weekly Semaglutide Shows Promise in Reducing Alcohol Consumption
A JAMA Psychiatry study shows weekly semaglutide significantly reduced alcohol cravings and heavy drinking days in 48 adults with alcohol use disorder, with nearly 40% of the semaglutide group reporting no heavy drinking days in the final month versus 20% in the placebo group.
Progress
40% Bias Score
Showing 1 to 2 of 2 results